Antrin motexafin lutetium: Phase I data; Phase II

PCYC presented data from 51 patients in which Antrin was well tolerated. Of the 43 patients with available angiograms, 19 showed improvement in minimal luminal diameter (MLD). Of the 47 patients evaluated by Rutherford-Becker classification and ankle-brachial index (ABI) measurements, which assess changes in symptoms due to treatment and the impact of the obstruction on blood pressure in the affected limb, respectively, improvement was observed in 62 and 57 percent of the patients, respectively. Data were presented at the European Society of Cardiology meeting in Barcelona. ...